Yue Zhou

发表

Outcomes for Surgery in Stage IA Large Cell Lung Neuroendocrine Compared With Other Types of Non-Small Cell Lung Cancer: A Propensity Score Matching Study Based on the Surveillance, Epidemiology, and End Results (SEER) Database

Zhengfei Zhu, Liqing Zou, T. Guo, 2020, Frontiers in Oncology.

Clinical outcomes of advanced non-small cell lung cancer patients harboring distinct subtypes of EGFR mutations and receiving first-line tyrosine kinase inhibitors: brain metastasis and de novo T790M matters

Zhengfei Zhu, T. Guo, Yue Zhou, 2022, BMC cancer.

Mechanisms and Implications of CDK4/6 Inhibitors for the Treatment of NSCLC

Zhengfei Zhu, Yue Zhou, Xi Yang, 2021, Frontiers in Oncology.

Neuroendocrine transformation from EGFR/ALK-wild type or TKI-naïve non-small cell lung cancer: An under-recognized phenomenon.

Xiaoyan Zhou, Yuan Li, Zhengfei Zhu, 2022, Lung cancer.

A brief report on incidence, radiographic feature and prognostic significance of brain MRI changes after anti-PD-1/PD-L1 therapy in advanced non-small cell lung cancer

Shengping Wang, Jie Hu, Zhengfei Zhu, 2021, Cancer Immunology, Immunotherapy.

Tumor angiogenesis at baseline identified by 18F-Alfatide II PET/CT may predict survival among patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy

Jinming Yu, X. Qin, S. Yuan, 2021, Journal of Translational Medicine.

Identification of a m6A RNA methylation regulators-based signature for predicting the prognosis of esophageal adenocarcinoma

Zhengfei Zhu, Liqing Zou, T. Guo, 2020 .

CAR-T Immunotherapy to Beat Solid Tumors: From Challenges to Improvements

Yue Zhou, Ziming Liu, Chentao Li, 2022, Highlights in Science, Engineering and Technology.

Low‐ dose Apatinib promotes vascular normalization and hypoxia reduction and sensitizes radiotherapy in lung cancer

Zhengfei Zhu, Liqing Zou, T. Guo, 2022, Cancer medicine.

Pattern of failure and clinical value of local therapy for oligo‐recurrence in locally advanced non‐small cell lung cancer after definitive chemoradiation: Impact of driver mutation status

Zhengfei Zhu, T. Guo, Yue Zhou, 2022, Cancer medicine.

Local Treatment of Non-small Cell Lung Cancer with a Spray-Dried Bevacizumab Formulation

P. Kuehl, David T. Vodak, Yue Zhou, 2021, AAPS PharmSciTech.

Brain metastases, patterns of intracranial progression, and the clinical value of upfront cranial radiotherapy in patients with metastatic non-small cell lung cancer treated with PD-1/PD-L1 inhibitors

S. Rizzo, W. Cho, Shengping Wang, 2022, Translational lung cancer research.

Overall survival benefit of osimertinib and clinical value of upfront cranial local therapy in untreated EGFR‐mutant nonsmall cell lung cancer with brain metastasis

Shengping Wang, T. Tong, Zhengfei Zhu, 2021, International journal of cancer.

Sintilimab, stereotactic body radiotherapy and granulocyte–macrophage colony stimulating factor as second-line therapy for advanced non-small cell lung cancer: safety run-in results of a multicenter, single-arm, phase II trial

Zhengfei Zhu, X. Ai, Xiaofei Wang, 2021, Radiation oncology.

Zhengfei Zhu, X. Ai, Xiaofei Wang, 2021, Radiation Oncology.

Clinical value of upfront cranial radiotherapy in osimertinib-treated EGFR-mutant non-small-cell lung cancer with brain metastases.

QUAN LIU, Shengping Wang, Yuan Li, 2021, International journal of radiation oncology, biology, physics.

Survival outcomes and symptomatic central nervous system (CNS) metastasis in EGFR-mutant advanced non-small cell lung cancer without baseline CNS metastasis: Osimertinib vs. first-generation EGFR tyrosine kinase inhibitors.

Shengping Wang, Zhengfei Zhu, Liqing Zou, 2020, Lung cancer.

The value of local consolidative therapy in Osimertinib-treated non-small cell lung cancer with oligo-residual disease

Xuwei Cai, Zhengfei Zhu, T. Guo, 2020, Radiation oncology.

Regulatory T Cells: An Emerging Player in Radiation-Induced Lung Injury

Zhengfei Zhu, Liqing Zou, T. Guo, 2020, Frontiers in Immunology.

A narrative review of evolving roles of radiotherapy in advanced non-small cell lung cancer: from palliative care to active player

Zhengfei Zhu, Liqing Zou, T. Guo, 2020, Translational lung cancer research.

Atypical Response in Metastatic Non-Small Cell Lung Cancer Treated with PD-1/PD-L1 Inhibitors: Radiographic Patterns and Clinical Value of Local Therapy

Zhengfei Zhu, T. Guo, Yue Zhou, 2022, Cancers.

Caution against simultaneous integrated boost radiotherapy for upper thoracic esophageal squamous cell carcinoma: results from a single-arm phase II trial

Zhengfei Zhu, T. Guo, Yue Zhou, 2023, Esophagus.

A Pilot Study of 18F-Alfatide PET/CT Imaging for Detecting Lymph Node Metastases in Patients with Non-Small Cell Lung Cancer

Jinming Yu, S. Yuan, Song Gao, 2017, Scientific Reports.

Lymph Node Maximum Uptake of 18F-ALF-NOTA-PRGD2 II PET/CT Predicts Lung Cancer Survival

Y. Pei, X. Qin, S. Yuan, 2020 .

Rationale and value of consolidative cranial local therapy in EGFR-mutant non-small cell lung cancer patients with baseline brain metastasis treated with first-line EGFR-TKIs

Zhengfei Zhu, T. Guo, Yue Zhou, 2023, Therapeutic advances in medical oncology.

PET/CT imaging reveals characteristics of angiogenesis in non-small cell lung cancer

Jinming Yu, Wei Zhao, S. Yuan, 2020 .

Development of Nomogram Models Based on Peripheral Blood Score and Clinicopathological Parameters to Predict Preoperative Advanced Stage and Prognosis for Epithelial Ovarian Cancer Patients

Yue Zhou, Peishu Liu, Sijing Qiao, 2023, Journal of inflammation research.

18F-RGD PET/CT imaging reveals characteristics of angiogenesis in non-small cell lung cancer

Jinming Yu, Wei Zhao, S. Yuan, 2020, Translational lung cancer research.

The efficacy of thoracic radiotherapy in extensive stage small cell lung cancer with baseline brain metastases: a multi-institutional retrospective cohort study

Zhengfei Zhu, Xun Yuan, Yue Zhou, 2023, Annals of translational medicine.

STING signaling activation modulates macrophage polarization via CCL2 in radiation-induced lung injury

Zhengfei Zhu, T. Guo, Yue Zhou, 2023, Journal of Translational Medicine.

Oligo-residual disease in PD-1/PD-L1 inhibitor-treated metastatic non-small cell lung cancer: incidence, pattern of failure, and clinical value of local consolidative therapy

T. Guo, Yue Zhou, L. Chu, 2024, Cancer immunology, immunotherapy : CII.

Potential synergistic effects of cranial radiotherapy and atezolizumab in non-small cell lung cancer: an analysis of individual patient data from seven prospective trials

T. Guo, Yue Zhou, J. Ni, 2024, Translational lung cancer research.

Sintilimab in combination with stereotactic body radiotherapy and granulocyte-macrophage colony-stimulating factor in metastatic non-small cell lung cancer: The multicenter SWORD phase 2 trial

Yue Zhou, J. Ni, Qian Chu, 2024, Nature communications.